Abstract: A method and system of physically solving the charge, mass, and current density functions of excited-state atoms and atomic ions using Maxwell's equations and computing and rendering the nature of excited-state electrons using the solutions. The results can be displayed on visual or graphical media. The display can be static or dynamic such that electron spin and rotation motion can be displayed in an embodiment. The displayed information is useful to anticipate reactivity and physical properties. The insight into the nature of excited-state electrons can permit the solution and display of those of other atoms and atomic ions and provide utility to anticipate their reactivity and physical properties as well as spectral absorption and emission to lead to new optical materials and light sources.

Abstract: Provided is a system of computing and rendering a nature of a chemical bond based on physical, Maxwellian solutions of charge, mass, and current density functions of hydrogen-type molecules and molecular ions. The system includes a processor for processing Maxwellian equations representing charge, mass, and current density functions of hydrogen-type molecules and molecular ions and an output device in communication with the processor for displaying the nature of the chemical bond.

Abstract: This invention relates to a reactor to generate power, plasma, light, and novel hydrogen compounds by the catalysis of atomic hydrogen. The power balance is optimized by maximizing the output power from the hydrogen catalysis reaction while minimizing the input power by controlling the parameters of the input power to initiate or at least partially maintain the plasma such as the power density, pulse frequency, duty cycle, and peak and offset electric fields.

Abstract: The present invention is a structural system and a method of fabricating the system comprised of finite elements called basis elements such as great circles or partial great circles to form a great-circle geodesic sphere, dome, or arch called a great sphere, dome, and arch, respectively. The structure is generated by forming a pattern of the basis element rotated at incremental angles about a rotational axis from an initial position to define a so-called primary component orbitsphere-cvf. The primary component orbitsphere defines a stationary pattern as well as a structural element called a secondary component orbitsphere-cvf that is constructed according to the pattern of the primary orbitsphere-cvf. The secondary component orbitsphere-cvf is initially oriented at the initial position and is incrementally rotated about the rotational axis to form the great-sphere-type structure.

Abstract: Provided is a system of computing and rendering a nature of a chemical bond based on physical, Maxwellian solutions of charge, mass, and current density functions of hydrogen-type molecules and molecular ions. The system includes a processor for processing Maxwellian equations representing charge, mass, and current density functions of hydrogen-type molecules and molecular ions and an output device in communication with the processor for displaying the nature of the chemical bond.

Abstract: The present invention relates to a cell, system, and methods to form diamond from carbon in a plasma formed or assisted by the catalysis of atomic hydrogen to lower energy states.

Abstract: Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug.